Dr.Jain'S Forest Herbals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 1.00 M
as on 06-07-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.81%
(FY 2019)
- Profit -0.31%
(FY 2019)
- Ebitda 27.10%
(FY 2019)
- Net Worth 5.41%
(FY 2019)
- Total Assets 3.36%
(FY 2019)
About Dr.Jain'S Forest Herbals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kinjal Mehta and Naman Sanghavi serve as directors at the Company.
- CIN/LLPIN
U24239MH1995PTC090319
- Company No.
090319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dr.Jain's Forest Herbals Private Limited offer?
Dr.Jain'S Forest Herbals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Care Products, Essential & Aromatic Oils, Spice Oil, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic, Herbal Oils and Cosmetics, Herbal Skin Care Cosmetics, Natural Flower Oil, Seeds Oil and Fruit Oils.
Who are the key members and board of directors at Dr.Jain'S Forest Herbals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naman Sanghavi  | Director | 18-Nov-2017 | Current |
| Kinjal Mehta | Director | 01-Jan-2014 | Current |
Financial Performance and Corporate Structure Insights of Dr.Jain'S Forest Herbals.
Dr.Jain'S Forest Herbals Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.81% decrease. The company also saw a slight decrease in profitability, with a 0.31% decrease in profit. The company's net worth moved up by a moderate rise of 5.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Jain'S Forest Herbals?
In 2019, Dr.Jain'S Forest Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr.Jain'S Forest Herbals?
Dr.Jain'S Forest Herbals has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Jain'S Forest Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Jain'S Forest Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
